Warburg pincus llc private company information – bloomberg cure type 1 diabetes naturally

Warburg Pincus LLC is a private equity and venture capital firm specializing in all stages of a company’s life cycle from founding startups, early-stage financings, growth equity investments, and developing companies to restructurings, recapitalizations, late stage, and management buyouts of mature businesses. The firm also invests in change in control leveraged buyout transactions, divisional spin-outs of non-core corporate assets, minority private investments in public companies, and special situations transactions with a focus on acquisition of undervalued companies and middle market companies. It typically invests energy; financial services; healthcare and life science; consumer; educati…

Warburg Pincus LLC is a private equity and venture capital firm specializing in all stages of a company’s life cycle from founding startups, early-stage financings, growth equity investments, and developing companies to restructurings, recapitalizations, late stage, and management buyouts of mature businesses.


The firm also invests in change in control leveraged buyout transactions, divisional spin-outs of non-core corporate assets, minority private investments in public companies, and special situations transactions with a focus on acquisition of undervalued companies and middle market companies. It typically invests energy; financial services; healthcare and life science; consumer; education services, software and systems; industrial and business services; technology, media and telecommunications; and real estate sectors. Within energy, it seeks to invest in oil and gas exploration and production, refining, upstream, midstream and oilfield services, power generation and transmission, alternative energy and renewables, mining and metals, and innovative energy technologies. Within financial services, the firm primarily invests in specialty and consumer finance, private banking, payment and transaction processing companies, insurance companies, financial technology, exchanges, banks, depository institutions, and asset and wealth management. Within healthcare and life sciences, the firm seeks to invest in biopharmaceuticals, healthcare services, consumer and digital health, medical devices, diagnostics, biotechnology, and specialty pharmaceuticals. In medical devices, it focuses on investments in diabetes, interventional cardiology, interventional neurology, orthopedics, and urology/gynecology. Within industrial and business services, it seeks opportunities in command, communication, and control equipment, business process outsourcing, financial technology and services, human capital management, information services, marketing services, regulatory and compliance services, risk management systems and services, specialty consulting and advisory services, supply chain and logistics services, and transaction processing. Within technology, media, and telecommunications, it typically invests in software, financial technology, business services, semiconductors and systems, information and internet. Within telecommunications, the firm invests in enabling technologies, enabling services, and service providers. Within real estate, the firm typically invests in homebuilding, retail, senior housing and assisted living facilities, lodging, self-storage development and real estate services, entity-level and asset-level investments and target distressed assets, non-performing loans, resort development, and hospitality. In software, the firm invests in industry-specific enterprise applications, information security, SaaS, computer and computer software stores, open source, and alternative business models, data center automation, and business intelligence, analytic applications, and decision support. In systems, the firm focuses on semiconductor devices for the china wireless market, programmable processors for audio, video, and data processing, mixed-signal, RF, and analog semiconductors, semiconductor-related software (embedded software, EDA Tools, and IP licensing), and systems and sub-systems driven by semiconductors (SoC, sensors, and optical components). The firm seeks to invest between $20 million and $1000 million in companies with enterprise values between $100 million and $15000 million. It seeks to invest globally with a focus on North America, Africa, Latin America, Europe, Brazil, Germany, India, South East Asia, China, Vietnam, Turkey, Italy, Ireland, and Asia. The firm has an average investment period between five years and seven years. It typically invests as a lead investor in transactions and takes a board seat in its portfolio companies. It usually takes a minority or majority stake in its companies. Warburg Pincus LLC was founded in 1939 and is based in New York, New York with additional offices in Asia, Europe, and North America.